The UK Government’s decision to confirm the indefinite recognition of CE-marked medical devices represents a significant development for the medical technology industry, providing manufacturers with greater regulatory certainty while helping to safeguard patient access to essential healthcare technologies across Great Britain.
Climate change is no longer a future sustainability issue – it is a present-day operational challenge for healthcare leaders. As temperatures continue to rise across the UK, pharmacy leaders are facing an increasingly complex question: how do we safeguard medicine quality when the environments in which medicines are stored were never designed for a hotter climate?
Climate change is rapidly becoming one of the defining challenges for healthcare. While much of the pharmaceutical sector’s sustainability agenda has focused on reducing carbon emissions, improving resource efficiency and meeting ambitious net-zero commitments, an equally important issue is beginning to emerge: adapting medicines management to a changing climate.
The latest announcement from Community Pharmacy England marks another significant milestone in what is becoming an increasingly unstable period for the UK medicines supply chain. With 204 price concessions agreed for April — surpassing the previous record of 201 concessions in March — the sector is witnessing sustained and escalating pricing volatility at a scale rarely seen before.
In today’s highly regulated pharmaceutical distribution landscape, the ability to audit effectively isn’t just a compliance requirement – it’s a defining characteristic of operational excellence. At the heart of every resilient quality system lies a structured, insightful, and well-executed audit process. That’s exactly where our Audit Training Package begins to distinguish itself.
